New treatment for thrombosis discovered

Mar 17, 2011

Scientists from the University of Reading have announced a major breakthrough in understanding how to control blood clotting which could lead to the development of new treatments and save the lives of thousands of people each year.

Doctors have known for some time that high levels of blood can increase the risk of suffering from a or a stroke. Controlling has therefore become an important way to reduce the risk of these serious diseases. This has led to the development of drugs that control the function of a protein within our bodies called LXR which regulates cholesterol.

However, researchers from the School of Biological Sciences have discovered that this protein has a double life.

The protein also appears to be involved in inhibiting the function of known as platelets, a role that is unconnected to cholesterol levels but which results in reducing the blood clotting response. In the research blood clot formation was inhibited by 40%.

Drugs that target LXR may therefore have benefit in reducing cardiovascular disease for two separate reasons: preventing , and controlling cholesterol levels.

Professor Jon Gibbins, Director of the University's Institute for Cardiovascular and Metabolic Research, said: "While blood clotting is essential to prevent bleeding, inappropriate clotting within the circulation, known as thrombosis, is the trigger for attacks and strokes - which kill more people in the UK each year than any other disease.

"This ground-breaking study paves the way for new and more effective medicines to prevent thrombosis."

The study was funded by the British Heart Foundation and Heart Research UK. Researchers found that targeting the LXR protein with anti-thrombotic drugs in mice reduced the size and stability of (thrombi). The treatment allowed initial thrombi to form (a physiological process necessary to prevent bleeding after injury to blood vessels) but reduced by approximately 40% the stability of the thrombi, preventing clots blocking blood vessels.

Collectively, heart and circulatory diseases cause more than one in three of all deaths in the UK, accounting for more than 191,000 deaths each year.

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, said: "Both anti-clotting and cholesterol-lowering drugs are vital in reducing the chance of a heart attack or stroke in high-risk patients, but are not always effective and don't suit all patients because of the risk of side-effects.

"This exciting discovery by Professor Gibbins' team shows that drugs which lower cholesterol through targeting LXR protein can also reduce harmful blood clotting - potentially opening up paths towards new, more effective treatments."

Explore further: Restrictions lifted at British bird flu farm

More information: The paper, LXR as a novel anti-thrombotic target, by Spyridon M, et al, appears in Blood, the journal of the American Society of Hematology.

Provided by University of Reading

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New clot-buster found

Jan 20, 2009

(PhysOrg.com) -- Exciting research into blood clotting by British Heart Foundation (BHF) researchers working at the University of Bristol will take us a step closer to better heart attack prevention and treatment. ...

Research explains link between cholesterol and heart disease

Sep 18, 2007

Cholesterol contributes to atherosclerosis – a condition that greatly increases the risk of heart attack and stroke – by suppressing the activity of a key protein that protects the heart and blood vessels, researchers ...

Recommended for you

Restrictions lifted at British bird flu farm

8 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.